Peter Kaiser, Chief Development Officer at OCULAR THERAPEUTIX, INC (OCUL), sold 19,306 shares at $11.03 ($213K) on 2025-10-02, disclosed to the SEC on 2025-10-06.
Scheduled sale ($213k) by Chief Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.03 | 9,653 | $106K | 50.0% |
| 2 | $11.03 | 9,653 | $106K | 50.0% |
| Total | $11.03 avg | 19,306 | $213K | 100% |
| Filing → |
| OCUL | SELL | 2026-05-28 | $24K | — | Filing → |
| OCUL | SELL | 2026-02-25 | $23K | — | Filing → |
| OCUL | SELL | 2025-11-26 | $36K | — | Filing → |